Insider · CIK 0001207604

LEWIS ALAN

Reports to the SEC for 4 companies · NOVATO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001207604

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-06-11	ASMBASSEMBLY BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-06-04	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+4,430 sh	—	—	25,590
2019-05-17	ASMBASSEMBLY BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2018-08-28	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	Director	MExercise/Conversion	+7,500 sh	$14.39	+$108K	28,660
2018-08-28	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	Director	SSale	−7,300 sh	$99.11	−$724K	21,360
2018-08-28	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	Director	SSale	−200 sh	$99.12	−$19.8K	21,160
2018-08-28	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (Right to buy Common Stock)M Exercise/Conversion	Director	MExercise/Conversion	−7,500 sh	—	—	0
2018-08-21	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	Director	SSale	−4,200 sh	$100.09	−$420K	21,160
2018-06-05	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+4,300 sh	—	—	25,360
2018-05-30	ASMBASSEMBLY BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2017-06-06	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+2,050 sh	—	—	26,060
2017-06-06	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy) Common StockA Award	Director	AAward	+4,910 sh	—	—	4,910
2017-06-01	ASMBASSEMBLY BIOSCIENCES, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2016-06-06	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+1,510 sh	—	—	24,010
2016-06-06	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (Right to buy) Common StockA Award	Director	AAward	+4,440 sh	—	—	4,400
2016-06-02	ASMBASSEMBLY BIOSCIENCES, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2015-12-18	ASMBASSEMBLY BIOSCIENCES, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2015-06-10	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+1,100 sh	—	—	22,500
2015-06-10	BMRNBIOMARIN PHARMACEUTICAL INC · Common Stock (right to buy)A Award	Director	AAward	+3,300 sh	—	—	3,300
2014-12-04	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	Director	MExercise/Conversion	+7,500 sh	$21.51	+$161K	28,900
2014-12-04	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	Director	SSale	−7,500 sh	$89.90	−$674K	21,400
2014-12-04	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,500 sh	—	—	0
2013-12-09	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$26.49	+$397K	34,300
2013-12-09	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	Director	MExercise/Conversion	+7,500 sh	$38.59	+$289K	41,800
2013-12-09	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	Director	SSale	−22.5K sh	$69.91	−$1.57M	19,300
2013-12-09	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2013-12-09	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,500 sh	—	—	0
2013-05-15	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+3,400 sh	—	—	19,300
2013-05-15	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy) Common StockA Award	Director	AAward	+8,500 sh	—	—	8,500
2013-05-15	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+3,400 sh	—	—	19,300
2013-05-15	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy) Common StockA Award	Director	AAward	+8,500 sh	—	—	8,500
2013-02-27	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	Director	MExercise/Conversion	+7,500 sh	$38.59	+$289K	23,400
2013-02-27	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	Director	MExercise/Conversion	+7,500 sh	$14.39	+$108K	30,900
2013-02-27	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	Director	MExercise/Conversion	+7,500 sh	$21.51	+$161K	38,400
2013-02-27	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	Director	SSale	−22.5K sh	$56.57	−$1.27M	15,900
2013-02-27	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy) Common StockM Exercise/Conversion	Director	MExercise/Conversion	−7,500 sh	—	—	61,000
2013-02-27	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy) Common StockM Exercise/Conversion	Director	MExercise/Conversion	−7,500 sh	—	—	53,500
2013-02-27	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy) Common StockM Exercise/Conversion	Director	MExercise/Conversion	−7,500 sh	—	—	46,000
2012-11-07	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$17.33	+$260K	30,900
2012-11-07	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	Director	SSale	−15K sh	$46.80	−$702K	15,900
2012-11-07	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy) Common StockM Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	68,500
2012-08-06	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	Director	MExercise/Conversion	+30K sh	$14.21	+$426K	55,900
2012-08-06	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	Director	SSale	−40K sh	$37.57	−$1.5M	15,900
2012-08-06	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy) Common StockM Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	83,500
2012-05-08	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+3,400 sh	—	—	25,900
2012-05-08	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy)A Award	Director	AAward	+8,500 sh	—	—	113,500
2011-05-12	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+2,500 sh	—	—	22,500
2011-05-12	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	105,000
2010-05-12	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director	AAward	+2,500 sh	—	—	20,000
2010-05-12	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	90,000

Recent filings

Accepted (ET)
Jun 154
LEWIS ALAN0001209191-20-036637
SEC(opens sec.gov)
Jun 64
LEWIS ALAN0001567619-19-012967
SEC(opens sec.gov)
May 174
LEWIS ALAN0001144204-19-027160
SEC(opens sec.gov)
Aug 304
LEWIS ALAN0001567619-18-001925
SEC(opens sec.gov)
Aug 224
LEWIS ALAN0001567619-18-001677
SEC(opens sec.gov)
Jun 74
LEWIS ALAN0001140361-18-027793
SEC(opens sec.gov)
Jun 14
LEWIS ALAN0001144204-18-032469
SEC(opens sec.gov)
Jun 84
BIOMARIN PHARMACEUTICAL INC0001140361-17-024508
SEC(opens sec.gov)
Jun 54
ASSEMBLY BIOSCIENCES, INC.0001144204-17-031030
SEC(opens sec.gov)
Jun 84
BIOMARIN PHARMACEUTICAL INC0001140361-16-069196
SEC(opens sec.gov)
Jun 34
ASSEMBLY BIOSCIENCES, INC.0001144204-16-106874
SEC(opens sec.gov)
Dec 214
ASSEMBLY BIOSCIENCES, INC.0001144204-15-071978
SEC(opens sec.gov)
Jun 184
BIOMARIN PHARMACEUTICAL INC0001140361-15-024798
SEC(opens sec.gov)
Dec 84
BIOMARIN PHARMACEUTICAL INC0001140361-14-044477
SEC(opens sec.gov)

Companies

Address

C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE

NOVATO, CA, 94949